Search results
DNA tests could help spot men most at risk of ‘under the radar’ prostate cancer
The US Sun· 6 days agoSCIENTISTS are developing a DNA test to tell if a man’s prostate cancer will come back. Patients who...
Prostate cancer: Supplement, keto diet may boost immunotherapy
Medical News Today· 2 days agoAbout 13% of cisgender men around the world will receive a prostate cancer diagnosis in their...
The nine things every man should know about prostate cancer
The Telegraph via Yahoo News· 3 days agoOpening up about their below-the-belt health is not a conversation every man wants to have with his...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
NBC 17 Raleigh· 14 hours agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment with ERLEADA® (apalutamide) and androgen deprivation therapy (ADT ...
Angle to Develop Prostate Cancer Liquid Biopsy Assay for AstraZeneca
GenomeWeb News· 16 hours agoAngle announced on Friday that it has signed a supplier agreement with AstraZeneca to develop an androgen receptor (AR) assay to assess prostate cancer ...
'Pivotal' new prostate screening trial 'could nearly HALVE deaths from disease'
The US Sun· 3 days agoA “PIVOTAL” prostate cancer screening trial could nearly halve deaths from the disease, scientists...
Keto supplement may improve immunotherapy for prostate cancer
Futurity· 4 days agoAdding a pre-ketone supplement, a component of a high-fat, low-carb ketogenic diet, to a type of ...
New Trials in Prostate Cancer: Could Your Patient Benefit?
Medscape· 5 days agoPerhaps one of your patients could benefit from a clinical trial that has recently opened in ...
Angle PLC Announces New Commercial Agreement with Large Pharma
Digital Journal· 24 hours agoANGLE commissioned to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies GUILDFORD, SURREY / ACCESSWIRE / May ...
Why selling to Novartis made sense for Mariana
BioPharma Dive via Yahoo Finance· 18 hours agoNovartis’ success with Pluvicto in prostate cancer has motivated others, Mariana among them, to follow into the field. “We began thinking in mid-2020...
